The aim of this study is to define mechanisms underlying the pharmacological effects of brain cholinesterase inhibition on cognitive function in patients with multiple sclerosis (MS). Both a Stroop task and an N-back task were used to probe the changes in brain activity using functional magnetic resonance imaging (fMRI) in a single (investigator)-blind, crossover treatment design studying 15 patients with multiple sclerosis (12 relapsing remitting, 3 secondary progressive) taking rivastigmine...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Cholinergic agonism alters cognitive processing and enhances brain functional connectivity in patients with multiple sclerosis.
If you are the owner of this record, you can report an update to it here: Report update to this record